Acurex Biosciences to Present at the Michael J. Fox Foundation Parkinson's Disease Therapeutics Conference | Region
SAN CARLOS, Calif.--(BUSINESS WIRE)--Oct 10, 2023--
Stay updated with breaking news from Silverstein Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN CARLOS, Calif.--(BUSINESS WIRE)--Oct 10, 2023--
First small molecule allosteric binder discovered with Gain’s computational drug discovery platform enters clinical developmentBETHESDA, Md., Oct. 04, 2023 -- Gain Therapeutics, Inc. , a...
First drug candidate identified with Gain’s proprietary computational drug discovery platform SEE-Tx® to enter clinical development phase BETHESDA, Md., Sept. 12, 2023 ...
Successfully completed GLP toxicology studies for lead program GT-02287 in GBA1 Parkinson’s diseaseCompany is on track to submit application for start of Phase 1 clinical trial of GT-02287 to... | May 12, 2023
BETHESDA, Md., May 03, 2023 -- Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced that Innosuisse, the... | May 3, 2023